Masato Okamoto

3.2k total citations
96 papers, 2.5k citations indexed

About

Masato Okamoto is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Masato Okamoto has authored 96 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Immunology, 46 papers in Oncology and 41 papers in Molecular Biology. Recurrent topics in Masato Okamoto's work include Immunotherapy and Immune Responses (42 papers), Cancer Immunotherapy and Biomarkers (22 papers) and Immune Response and Inflammation (20 papers). Masato Okamoto is often cited by papers focused on Immunotherapy and Immune Responses (42 papers), Cancer Immunotherapy and Biomarkers (22 papers) and Immune Response and Inflammation (20 papers). Masato Okamoto collaborates with scholars based in Japan, United States and France. Masato Okamoto's co-authors include Mitsunobu Sato, Ryoichi Oyasu, Shigeo Koido, Shigetaka Shimodaira, Tetsuya Oshikawa, Sadamu Homma, Sharif Ahmed, Shin Kan, Motoo Saito and Tomoyuki Tano and has published in prestigious journals such as PLoS ONE, Cancer and Cancer Research.

In The Last Decade

Masato Okamoto

94 papers receiving 2.4k citations

Peers

Masato Okamoto
Jay Friedman United States
Sofia Edin Sweden
Arianna Calcinotto Italy
Katharina Detjen Germany
Min Hee Oh United States
Mingye Feng United States
Maria Grazia Totaro Italy
Sarah Schwitalla Germany
Marie‐Luise Kruse Germany
Lyse A. Norian United States
Jay Friedman United States
Masato Okamoto
Citations per year, relative to Masato Okamoto Masato Okamoto (= 1×) peers Jay Friedman

Countries citing papers authored by Masato Okamoto

Since Specialization
Citations

This map shows the geographic impact of Masato Okamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masato Okamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masato Okamoto more than expected).

Fields of papers citing papers by Masato Okamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masato Okamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masato Okamoto. The network helps show where Masato Okamoto may publish in the future.

Co-authorship network of co-authors of Masato Okamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Masato Okamoto. A scholar is included among the top collaborators of Masato Okamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masato Okamoto. Masato Okamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Takahashi, Hidenori, Shigetaka Shimodaira, Masahiro Ogasawara, et al.. (2016). Lung adenocarcinoma may be a more susceptive subtype to a dendritic cell-based cancer vaccine than other subtypes of non-small cell lung cancers: a multicenter retrospective analysis. Cancer Immunology Immunotherapy. 65(9). 1099–1111. 18 indexed citations
2.
Okamoto, Masato. (2016). Dendritic cell-based vaccine for pancreatic cancer in Japan. World Journal of Gastrointestinal Pharmacology and Therapeutics. 7(1). 133–133. 25 indexed citations
3.
Kan, Shin, Shigeo Koido, Masato Okamoto, et al.. (2015). Gemcitabine treatment enhances HER2 expression in low HER2-expressing breast cancer cells and enhances the antitumor effects of trastuzumab emtansine. Oncology Reports. 34(1). 504–510. 25 indexed citations
4.
5.
Koido, Shigeo, Sadamu Homma, Shin Kan, et al.. (2014). Induction of antigen-specific cytotoxic T lymphocytes by fusion cells generated from allogeneic plasmacytoid dendritic and tumor cells. International Journal of Oncology. 45(1). 470–478. 8 indexed citations
6.
7.
Kobayashi, Masanori, Asako Chiba, Akihito Nakajima, et al.. (2014). Therapeutic effect of intratumoral injections of dendritic cells for locally recurrent gastric cancer: a case report. World Journal of Surgical Oncology. 12(1). 390–390. 9 indexed citations
8.
Koido, Shigeo, Sadamu Homma, Masato Okamoto, et al.. (2013). Strategies to improve the immunogenicity of anticancer vaccines based on dendritic cell/malignant cell fusions. OncoImmunology. 2(9). e25994–e25994. 11 indexed citations
9.
Koido, Shigeo, Sadamu Homma, Masato Okamoto, et al.. (2013). Fusions between dendritic cells and whole tumor cells as anticancer vaccines. OncoImmunology. 2(5). e24437–e24437. 40 indexed citations
10.
Furuta, Hiroyuki, Kenji Osawa, Masashi Shin, et al.. (2012). Selective inhibition of NF‐κB suppresses bone invasion by oral squamous cell carcinoma in vivo. International Journal of Cancer. 131(5). E625–35. 30 indexed citations
11.
Tano, Tomoyuki, Masato Okamoto, Shin Kan, et al.. (2012). Growth inhibition and apoptosis by an active component of OK-432, a streptococcal agent, via Toll-like receptor 4 in human head and neck cancer cell lines. Oral Oncology. 48(8). 678–685. 13 indexed citations
12.
Tsukada, Jun, Takeshi Tomoda, Hidenori Takahashi, et al.. (2011). Clinical and Immunologic Evaluation of Dendritic Cell–Based Immunotherapy in Combination With Gemcitabine and/or S-1 in Patients With Advanced Pancreatic Carcinoma. Pancreas. 41(2). 195–205. 123 indexed citations
13.
Ramos, Freddy A., Yoshihisa Takaishi, Kazuyoshi Kawazoe, et al.. (2006). Immunosuppressive diacetylenes, ceramides and cerebrosides from Hydrocotyle leucocephala. Phytochemistry. 67(11). 1143–1150. 25 indexed citations
14.
Oshikawa, Tetsuya, Masato Okamoto, Tomoyuki Tano, et al.. (2006). Antitumor Effect of OK-432–Derived DNA. Journal of Immunotherapy. 29(2). 143–150. 21 indexed citations
15.
Okamoto, Masato, Sachiko Furuichi, Tomoyuki Tano, Hideo Yoshida, & Mitsunobu Sato. (2004). Intratumoral administration of dendritic cells in combination with TS-1, an oral fluoropyrimidine anti-cancer drug, and OK-432, a streptococcal agent. 53(1). 14–21. 2 indexed citations
16.
Ahmed, Sharif, Masato Okamoto, Tetsuya Oshikawa, et al.. (2004). Anti-Tumor Effect of an Intratumoral Administration of Dendritic Cells in Combination with TS-1, an Oral Fluoropyrimidine Anti-Cancer Drug, and OK-432, a Streptococcal Immunopotentiator. Journal of Immunotherapy. 27(6). 432–441. 30 indexed citations
17.
18.
Okamoto, Masato, Tetsuya Oshikawa, Go Ohe, et al.. (2001). Comparison of cytokine-inducing activity in a lipoteichoic acid-related molecule isolated from a penicillin-killed group A Streptococcus and from untreated bacteria. International Immunopharmacology. 1(11). 1957–1968. 16 indexed citations
19.
Okamoto, Masato, Janardan K. Reddy, & Ryoichi Oyasu. (1997). Tumorigenic conversion of a non-tumorigenic rat urothelial cell line by overexpression of H2O2-generating peroxisomal fatty acyl-CoA oxidase. International Journal of Cancer. 70(6). 716–721. 26 indexed citations
20.
Shioda, Seiji, et al.. (1993). Immunocytochemical localization of nicotinic acetylcholine receptor in rat hypothalamus. Brain Research. 625(1). 145–151. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jay Friedman Breakdown of academic impact, for papers by Sofia Edin Breakdown of academic impact, for papers by Arianna Calcinotto Breakdown of academic impact, for papers by Katharina Detjen Breakdown of academic impact, for papers by Min Hee Oh Breakdown of academic impact, for papers by Mingye Feng Breakdown of academic impact, for papers by Maria Grazia Totaro Breakdown of academic impact, for papers by Sarah Schwitalla Breakdown of academic impact, for papers by Marie‐Luise Kruse Breakdown of academic impact, for papers by Lyse A. Norian
Rankless by CCL
2026